Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-02-21 @ 8:26 AM
Study NCT ID:
NCT02706405
Status:
TERMINATED
Last Update Posted:
2022-08-24
First Post:
2016-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-24
First Submit QC Date:
None
Study First Post Date:
2016-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-05-06
Results First Submit QC Date:
None
Results First Post Date:
2022-08-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-01
Last Update Post Date:
2022-08-24
Last Update Post Date Type:
ACTUAL